News
Website-Relaunch of Dr. Erkens Consulting Group
We have used the summer vacation and the current restrictions due to the Covid-19 pandemic to completely redesign our website and provide it with new content.
The website of the Dr. Erkens Consulting Group officially goes online on 03 September 2020, and in addition to corporate information about the Dr. Erkens Consulting Group and its range of services it offers many other features such as current information from the health industry, regular blog posts on topics relating to marketing and sales, and much more.
We have been supported in the creation of our new and completely responsive website by our longstanding partner be-sign.net.
Integrated Pharma-News at Dr. Erkens Consulting Group Website
Adress
Dr. Erkens Consulting Group
IndustriestraĂźe 13
64380 RoĂźdorf
Tel: +49 (0)6154 – 6967 – 944
Mobil +49 (0)179 – 2 41 10 29
info@dr-erkens-consulting.de
News
Dr. Erkens Consulting Group
- Website-Relaunch of Dr. Erkens Consulting Group
Source: Dr. Erkens Consulting Group 09/2020 - Integrated Pharma-News at Dr. Erkens Consulting Group Website
Source: Dr. Erkens Consulting Group 09/2020
Pharma Letter
- BRIEF—Idorsia in talks to sell Asia-Pacific business
- Coherus and Mark Cuban to debut lowest priced Humira biosimilar in USA
- US biotech industry keeps up fight against Inflation Reduction Act
- Keytruda combo could unlock potential of arenaviral tech
- BRIEF—AstraZeneca drops brazikumab development program
Pharma Relations
- Gemeinsam für mehr Aufklärung: Bayer Vital startet Initiative „EyeOpener“ mit Experten und Patienten
- Neuer Pharma-Partner: Inizio Engage bĂĽndelt strategische Engagement-Services
- Schmittgall Health: Launchkampagne fĂĽr eine neue und einzigartige Zweifachkombination bei Hypertonie
- Maximilian Hess kehrt als Director zu MSL zurĂĽck
- BVMed: Bevölkerungsumfrage zur Krankenhausreform
Pharma Times
- New COVID-19 vaccine successfully tested
- Biocomposites embraces NanoBone technology following acquisition of Artoss GmbH
- AstraZeneca’s Tagrisso delivers positive results
- Element to increases lab equipment presence
- BioInvent receives Investigational New Drug approval for monoclonal antibody BI-1910
PZ online
- Orale Antitumortherapie: Pharmazeutische Betreuung hilft
- Reform EU-Arzneimittelrecht: ABDA warnt BMG vor digitalem Beipackzettel
- Schimmelbildung: Wie lässt sich die Qualität von Cannabisblüten verbessern?
- Organspende-Bereitschaft: Es kann jeden treffen – Entscheidung dokumentieren
- Westfalen-Lippe: Flexiblere Ă–ffnungszeiten fĂĽr Apotheken in Aussicht
Our Place on Earth

Kartenbild: OpenStreetMap, ODbL 1.0